Publication: Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation
cris.virtual.author-orcid | 0000-0002-8766-7945 | |
cris.virtualsource.author-orcid | 6a6cce22-76f9-4574-bec7-eef105711d83 | |
cris.virtualsource.author-orcid | 31134751-5aa4-429b-82a9-a4f94bac9190 | |
cris.virtualsource.author-orcid | f066d906-a45d-4400-9e07-830bd9478529 | |
cris.virtualsource.author-orcid | b7cda86d-8924-42a5-973a-d73fee5c630b | |
cris.virtualsource.author-orcid | 6ce71754-7a3b-4465-a292-74e57d257bfa | |
cris.virtualsource.author-orcid | 95ec6bf0-8d46-4933-a079-43a43dfc0a37 | |
cris.virtualsource.author-orcid | b8b97d17-faf0-45a5-8e1b-a09da9444493 | |
cris.virtualsource.author-orcid | c529060d-47dc-48e2-8411-a486c8315a3f | |
cris.virtualsource.author-orcid | 617422e9-33ec-4bfe-9a5b-00dbb5dfed38 | |
cris.virtualsource.author-orcid | b620722a-f94f-4ba9-b338-16a38af6d7d0 | |
cris.virtualsource.author-orcid | 101f1394-72d5-4dda-b28f-666a3dee6c70 | |
cris.virtualsource.author-orcid | d73f6cf6-4a67-4870-9076-e185a1726ff0 | |
datacite.rights | open.access | |
dc.contributor.author | O'Sullivan, Crochan John | |
dc.contributor.author | Stortecky, Stefan | |
dc.contributor.author | Heg, Dierik Hans | |
dc.contributor.author | Pilgrim, Thomas | |
dc.contributor.author | Hosek, Nicola | |
dc.contributor.author | Büllesfeld, Lutz | |
dc.contributor.author | Khattab, Ahmed Aziz | |
dc.contributor.author | Nietlispach, Fabian | |
dc.contributor.author | Moschovitis, Aris | |
dc.contributor.author | Zanchin, Thomas | |
dc.contributor.author | Meier, Bernhard | |
dc.contributor.author | Windecker, Stephan | |
dc.contributor.author | Wenaweser, Peter Martin | |
dc.date.accessioned | 2024-10-14T16:00:42Z | |
dc.date.available | 2024-10-14T16:00:42Z | |
dc.date.issued | 2013 | |
dc.description.abstract | AIMS Our aim was to evaluate the invasive haemodynamic indices of high-risk symptomatic patients presenting with 'paradoxical' low-flow, low-gradient, severe aortic stenosis (AS) (PLF-LG) and low-flow, low-gradient severe AS (LEF-LG) and to compare clinical outcomes following transcatheter aortic valve implantation (TAVI) among these challenging AS subgroups. METHODS AND RESULTS Of 534 symptomatic patients undergoing TAVI, 385 had a full pre-procedural right and left heart catheterization. A total of 208 patients had high-gradient severe AS [HGAS; mean gradient (MG) ≥40 mmHg], 85 had PLF-LG [MG ≤ 40 mmHg, indexed aortic valve area [iAVA] ≤0.6 cm(2) m(-2), stroke volume index ≤35 mL/m(2), ejection fraction (EF) ≥50%], and 61 had LEF-LG (MG ≤ 40 mmHg, iAVA ≤0.6 cm(2) m(-2), EF ≤40%). Compared with HGAS, PLF-LG and LEF-LG had higher systemic vascular resistances (HGAS: 1912 ± 654 vs. PLF-LG 2006 ± 586 vs. LEF-LG 2216 ± 765 dyne s m(-5), P = 0.007) but lower valvulo-arterial impedances (HGAS: 7.8 ± 2.7 vs. PLF-LG 6.9 ± 1.9 vs. LEF-LG 7.7 ± 2.5 mmHg mL(-1) m(-2), P = 0.027). At 30 days, no differences in cardiac death (6.5 vs. 4.9 vs. 6.6%, P = 0.90) or death (8.4 vs. 6.1 vs. 6.6%, P = 0.88) were observed among HGAS, PLF-LG, and LEF-LG groups, respectively. At 1 year, New York Heart Association functional improvement occurred in most surviving patients (HGAS: 69.2% vs. PLF-LG 71.7% vs. LEF-LG 89.3%, P = 0.09) and no significant differences in overall mortality were observed (17.6 vs. 20.5 vs. 24.5%, P = 0.67). Compared with HGAS, LEF-LG had a higher 1 year cardiac mortality (adjusted hazard ratio 2.45, 95% confidence interval 1.04-5.75, P = 0.04). CONCLUSION TAVI in PLF-LG or LEF-LG patients is associated with overall mortality rates comparable with HGAS patients and all groups profit symptomatically to a similar extent. | |
dc.description.numberOfPages | 14 | |
dc.description.sponsorship | Universitätsklinik für Kardiologie | |
dc.description.sponsorship | Institut für Sozial- und Präventivmedizin (ISPM) | |
dc.description.sponsorship | Institut für Anatomie | |
dc.identifier.doi | 10.7892/boris.41944 | |
dc.identifier.pmid | 24096324 | |
dc.identifier.publisherDOI | 10.1093/eurheartj/eht408 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/113611 | |
dc.language.iso | en | |
dc.publisher | Oxford University Press | |
dc.relation.ispartof | European Heart Journal | |
dc.relation.issn | 0195-668X | |
dc.relation.organization | DCD5A442BCD7E17DE0405C82790C4DE2 | |
dc.relation.organization | DCD5A442BECFE17DE0405C82790C4DE2 | |
dc.relation.organization | DCD5A442BE42E17DE0405C82790C4DE2 | |
dc.relation.organization | DCD5A442BB15E17DE0405C82790C4DE2 | |
dc.subject | Aortic stenosis | |
dc.subject | Hemodynamics | |
dc.subject | Transcatheter aortic valve implantation | |
dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
dc.subject.ddc | 300 - Social sciences, sociology & anthropology::360 - Social problems & social services | |
dc.title | Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation | |
dc.type | article | |
dspace.entity.type | Publication | |
dspace.file.type | text | |
oaire.citation.endPage | 50 | |
oaire.citation.issue | 44 | |
oaire.citation.startPage | 3437 | |
oaire.citation.volume | 34 | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Institut für Sozial- und Präventivmedizin (ISPM) | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Institut für Anatomie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation | Universitätsklinik für Kardiologie | |
oairecerif.author.affiliation2 | Departement Klinische Forschung, Core Facility, Clinical Trials Unit (CTU) Bern | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.date.licenseChanged | 2019-10-31 21:43:21 | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 41944 | |
unibe.journal.abbrevTitle | EUR HEART J | |
unibe.refereed | true | |
unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- O'Sullivan EurHeartJ 2013.pdf
- Size:
- 1.06 MB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- publisher
- Content:
- published